Related Experiment Videos
Oncology clinical trials
Abstract:
In 1971, President Nixon declared a "war on cancer" and initiated substantial funding for the National Cancer Program, which has been sustained through the years with a significant return on investment. Recently released 1998 statistics from the National Cancer Institute (NCI), the Centers for Disease Control and Prevention, and the American Cancer Society show the first real decline in cancer since the 1930s. Still, more than 1.2 million Americans will be diagnosed with cancer this year. New developments in biomedicine and advances in science and technology likely will lead to greater declines in cancer incidence and mortality.
Insights
The "war on cancer" has led to a decline in cancer rates since the 1930s. Continued biomedical advances promise further reductions in cancer incidence and mortality.
Area of Science:
- Oncology
- Public Health
- Biomedical Science
Background:
- The National Cancer Program, initiated in 1971, has seen sustained investment.
- Cancer incidence and mortality have been tracked by major health organizations.
- Significant progress has been made in understanding and combating cancer.
Purpose of the Study:
- To review the impact of the National Cancer Program on cancer statistics.
- To highlight recent trends in cancer incidence and mortality.
- To project future impacts of scientific and technological advancements on cancer outcomes.
Main Methods:
- Analysis of cancer statistics from the National Cancer Institute (NCI), Centers for Disease Control and Prevention (CDC), and American Cancer Society (ACS).
- Review of historical funding and investment in cancer research.
- Assessment of emerging biomedical and technological developments relevant to cancer treatment and prevention.
Main Results:
- Cancer statistics show the first significant decline since the 1930s.
- Over 1.2 million Americans are diagnosed with cancer annually.
- Sustained investment in the National Cancer Program demonstrates a positive return.
Conclusions:
- The "war on cancer" has yielded measurable success in reducing cancer rates.
- Ongoing scientific and technological advancements are expected to further decrease cancer incidence and mortality.
- Continued research and investment are crucial for future progress in oncology.